Enliven Therapeutics shares owned by Commodore Capital
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Commodore Capital
from 13F filings
Historical chart of Commodore Capital investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Commodore Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $96M | 4.7M | 20.47 |
| 2025-06-30 | $94M | 4.7M | 20.06 |
| 2025-03-31 | $92M | 4.7M | 19.68 |
| 2024-12-31 | $95M | 4.2M | 22.50 |
| 2024-09-30 | $105M | 4.1M | 25.54 |
| 2024-06-30 | $93M | 4.0M | 23.37 |
| 2024-03-31 | $70M | 4.0M | 17.59 |
| 2023-12-31 | $40M | 2.9M | 13.84 |
| 2023-09-30 | $40M | 2.9M | 13.66 |
| 2023-06-30 | $48M | 2.3M | 20.41 |
| 2023-03-31 | $38M | 1.7M | 21.90 |